Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Other Non-Current Liabilities (2024 - 2026)

Updated

Nuvalent's Other Non-Current Liabilities was $75.73 million in Q1 2026, up 291.0% from $19.37 million a year earlier and up 3.5% from the prior quarter.

Analysis

Nuvalent (NUVL) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Other Non-Current Liabilities at Nuvalent came in at $73.16 million, up 307.8% from FY2024.

  • In earlier years, Other Non-Current Liabilities was $17.94 million in FY2024.
  • Compared with a year earlier, Other Non-Current Liabilities has increased for three straight quarters.
  • Per Business Quant data, NUVL's Other Non-Current Liabilities in the three quarters before Q1 2026 was $73.16 million (Q4 2025), $45.22 million (Q3 2025) and $25.41 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Nuvalent 9.75 Bn 9.75 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 75.73 Mn
Dec 31, 2025 73.16 Mn
Sep 30, 2025 45.22 Mn
Jun 30, 2025 25.41 Mn
Mar 31, 2025 19.37 Mn
Dec 31, 2024 17.94 Mn
Sep 30, 2024 16.60 Mn
API Access

Nuvalent Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NUVL&period=max&api_key=YOUR_API_KEY